重症感染-话题@MedSci

#重症感染#

16篇内容 | 1361人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2169975, encodeId=da4121699e504, content=<a href='/topic/show?id=f6e513111bc' target=_blank style='color:#2F92EE;'>#NT-proBNP#</a> <a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a> <a href='/topic/show?id=2a575331391' target=_blank style='color:#2F92EE;'>#感染性休克#</a>, objectTitle=重症感染及感染性休克的生物标志物：听听心脏怎么说？, objectType=article, longId=801530, objectId=699b8015303a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=699b8015303a, replyNumber=0, likeNumber=40, createdTime=2023-11-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=699b8015303a, moduleTitle=重症感染及感染性休克的生物标志物：听听心脏怎么说？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=699b8015303a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2124025, encodeId=a78d2124025c1, content=<a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a>有所收获, objectTitle=何为SAA（血清淀粉样蛋白A）？, objectType=article, longId=765552, objectId=5e36e65552c4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/diagnostic-form-in-hospital-conceptual-image-7JAH3GT.jpg, objectUrl=/article/show_article.do?id=5e36e65552c4, replyNumber=0, likeNumber=49, createdTime=2023-04-06, rootId=0, userName=1013100771, userId=2d114843943, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=山东省, moduleDTOList=[ModuleDTO(moduleId=5e36e65552c4, moduleTitle=何为SAA（血清淀粉样蛋白A）？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e36e65552c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2104749, encodeId=c6f72104e49fb, content=<a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a>学习, objectTitle=重症感染, objectType=topic, longId=95948, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=32, createdTime=2022-12-07, rootId=0, userName=ms3000001090877961, userId=793e8459365, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1075159, encodeId=739510e51596c, content=<a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a>参与, objectTitle=重症感染, objectType=topic, longId=95948, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=65, createdTime=2021-11-29, rootId=0, userName=1792186248@qq.com, userId=671a5602834, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1074541, encodeId=2ec610e454186, content=<a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a>学习交流, objectTitle=重症感染, objectType=topic, longId=95948, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=52, createdTime=2021-11-27, rootId=0, userName=1792186248@qq.com, userId=671a5602834, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1062749, encodeId=be901062e4933, content=<a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a>学习, objectTitle=重症感染, objectType=topic, longId=95948, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=51, createdTime=2021-10-21, rootId=0, userName=ms4000000654879381, userId=994a5643790, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1061508, encodeId=a1991061508d0, content=<a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a>学习, objectTitle=重症感染, objectType=topic, longId=95948, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=65, createdTime=2021-10-18, rootId=0, userName=涂涂0518, userId=8d772453344, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1053169, encodeId=64da105316924, content=<a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a>参与, objectTitle=重症感染, objectType=topic, longId=95948, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=67, createdTime=2021-09-20, rootId=0, userName=涂涂0518, userId=8d772453344, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=900536, encodeId=786890053616, content=<a href='/topic/show?id=0263889984b' target=_blank style='color:#2F92EE;'>#血型#</a> <a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> <a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a> 血型会影响新冠感染、插管和死亡几率，无疑为新冠重症感染以及降低重症感染患者的插管率提供了新的诊疗思路, objectTitle=Nat Commun：你是什么血型？血型会影响新冠感染、插管和死亡几率, objectType=article, longId=203384, objectId=65f820338490, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/160602_CELLChallenge1.jpg, objectUrl=/article/show_article.do?id=65f820338490, replyNumber=0, likeNumber=0, createdTime=2020-11-19, rootId=0, userName=BJying, userId=fb825296401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65f820338490, moduleTitle=Nat Commun：你是什么血型？血型会影响新冠感染、插管和死亡几率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65f820338490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=900535, encodeId=ae25900535ac, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a> <a href='/topic/show?id=15819594847' target=_blank style='color:#2F92EE;'>#重症感染#</a> <a href='/topic/show?id=0f6c1530680' target=_blank style='color:#2F92EE;'>#Remdesivir#</a> 刚结束不久的中华医学会呼吸病学年会上，钟南山院士也不建议在重症感染患者中应用remdesivir。, objectTitle=世界顶级重症监护机构建议：重症新冠COVID-19感染患者不要使用remdesivir, objectType=article, longId=203469, objectId=922920346906, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20201113/d7689e12b9af466ebc068d9b521b10b7.jpg, objectUrl=/article/show_article.do?id=922920346906, replyNumber=0, likeNumber=138, createdTime=2020-11-19, rootId=0, userName=BJying, userId=fb825296401, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=922920346906, moduleTitle=世界顶级重症监护机构建议：重症新冠COVID-19感染患者不要使用remdesivir, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=922920346906)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

重症感染

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#NT-proBNP# #重症感染# #感染性休克#

重症感染及感染性休克的生物标志物：听听心脏怎么说？

2023-11-21发表于上海

1013100771 (审核中...)

前往app查看评论内容

#重症感染#有所收获

何为SAA（血清淀粉样蛋白A）？

2023-04-06发表于山东省

ms3000001090877961 (审核中...)

前往app查看评论内容

#重症感染#学习

2022-12-07

1792186248@qq.com (审核中...)

前往app查看评论内容

#重症感染#参与

2021-11-29

1792186248@qq.com (审核中...)

前往app查看评论内容

#重症感染#学习交流

2021-11-27

ms4000000654879381 (审核中...)

前往app查看评论内容

#重症感染#学习

2021-10-21

涂涂0518 (审核中...)

前往app查看评论内容

#重症感染#学习

2021-10-18

涂涂0518 (审核中...)

前往app查看评论内容

#重症感染#参与

2021-09-20

BJying (审核中...)

前往app查看评论内容

#血型# #新冠肺炎# #重症感染# 血型会影响新冠感染、插管和死亡几率，无疑为新冠重症感染以及降低重症感染患者的插管率提供了新的诊疗思路

Nat Commun：你是什么血型？血型会影响新冠感染、插管和死亡几率

2020-11-19

BJying (审核中...)

前往app查看评论内容

#新冠肺炎# #重症感染# #Remdesivir# 刚结束不久的中华医学会呼吸病学年会上，钟南山院士也不建议在重症感染患者中应用remdesivir。

世界顶级重症监护机构建议：重症新冠COVID-19感染患者不要使用remdesivir

2020-11-19

科室
- - 订阅+
  - 更多科室
工具
服务